CT1195E
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for CT1195E, covering 2025-11-18 to 2026-01-21. Get the full timeline:
Most recent: Clinical Trial Update: Safety, Efficacy and Cellular Metabolic Dynamics of CT1195E in Patients With Refractory / Progressive SSC [EARLY_Phase 1]